Company intelligence
Terumo Neuro
Formerly MicroVention
About Terumo Neuro
We’re in business to create and deliver innovations that redefine what’s possible in neurovascular treatment, meaningfully advancing both physician practice and patient outcomes. Founded in 1997 as MicroVention and acquired by Terumo Corporation in 2006, Terumo Neuro offers more than thirty products for the treatment of cerebral aneurysms, ischemic stroke, carotid artery disease, and neurovascular malformations. Headquartered in California, Terumo Neuro products are sold in more than seventy countries through a direct sales organization as well as strategic distribution partnerships. Manufacturing facilities are in Aliso Viejo, California, and San José, Costa Rica.
Verified activity
Signals from Terumo Neuro
4 published signals
Presence & Recognition
Terumo Neuro hosted an Industry Symposium at the ESMINT Society in Marseille focused on SOFIA Flow 88 and the evolving role of aspiration in stroke treatment.
Reported by Terumo Neuro
Presence & Recognition
Terumo Neuro represented the company at an event hosted by AdvaMed and the FDA.
Reported by Manchi Cheung
Presence & Recognition
Terumo Neuro is exhibiting at Booth 5 at the ESMINT Society during ESMINT 2026, featuring the WEB device and a Silent Symposium at 4:00 PM.
Reported by Terumo Neuro